Cargando…

Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides

Proteostasis is critical to maintain organismal viability, a process counteracted by aging-dependent protein aggregation. Chaperones of the heat shock protein (HSP) family help control proteostasis by reducing the burden of unfolded proteins. They also oversee the formation of protein aggregates. He...

Descripción completa

Detalles Bibliográficos
Autores principales: Truttmann, Matthias C., Pincus, David, Ploegh, Hidde L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: National Academy of Sciences 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984528/
https://www.ncbi.nlm.nih.gov/pubmed/29760078
http://dx.doi.org/10.1073/pnas.1801989115
_version_ 1783328630695264256
author Truttmann, Matthias C.
Pincus, David
Ploegh, Hidde L.
author_facet Truttmann, Matthias C.
Pincus, David
Ploegh, Hidde L.
author_sort Truttmann, Matthias C.
collection PubMed
description Proteostasis is critical to maintain organismal viability, a process counteracted by aging-dependent protein aggregation. Chaperones of the heat shock protein (HSP) family help control proteostasis by reducing the burden of unfolded proteins. They also oversee the formation of protein aggregates. Here, we explore how AMPylation, a posttranslational protein modification that has emerged as a powerful modulator of HSP70 activity, influences the dynamics of protein aggregation. We find that adjustments of cellular AMPylation levels in Caenorhabditis elegans directly affect aggregation properties and associated toxicity of amyloid-β (Aβ), of a polyglutamine (polyQ)-extended polypeptide, and of α-synuclein (α-syn). Expression of a constitutively active C. elegans AMPylase FIC-1(E274G) under its own promoter expedites aggregation of Aβ and α-syn, and drastically reduces their toxicity. A deficiency in AMPylation decreases the cellular tolerance for aggregation-prone polyQ proteins and alters their aggregation behavior. Overexpression of FIC-1(E274G) interferes with cell survival and larval development, underscoring the need for tight control of AMPylase activity in vivo. We thus define a link between HSP70 AMPylation and the dynamics of protein aggregation in neurodegenerative disease models. Our results are consistent with a cytoprotective, rather than a cytotoxic, role for such protein aggregates.
format Online
Article
Text
id pubmed-5984528
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher National Academy of Sciences
record_format MEDLINE/PubMed
spelling pubmed-59845282018-06-07 Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides Truttmann, Matthias C. Pincus, David Ploegh, Hidde L. Proc Natl Acad Sci U S A PNAS Plus Proteostasis is critical to maintain organismal viability, a process counteracted by aging-dependent protein aggregation. Chaperones of the heat shock protein (HSP) family help control proteostasis by reducing the burden of unfolded proteins. They also oversee the formation of protein aggregates. Here, we explore how AMPylation, a posttranslational protein modification that has emerged as a powerful modulator of HSP70 activity, influences the dynamics of protein aggregation. We find that adjustments of cellular AMPylation levels in Caenorhabditis elegans directly affect aggregation properties and associated toxicity of amyloid-β (Aβ), of a polyglutamine (polyQ)-extended polypeptide, and of α-synuclein (α-syn). Expression of a constitutively active C. elegans AMPylase FIC-1(E274G) under its own promoter expedites aggregation of Aβ and α-syn, and drastically reduces their toxicity. A deficiency in AMPylation decreases the cellular tolerance for aggregation-prone polyQ proteins and alters their aggregation behavior. Overexpression of FIC-1(E274G) interferes with cell survival and larval development, underscoring the need for tight control of AMPylase activity in vivo. We thus define a link between HSP70 AMPylation and the dynamics of protein aggregation in neurodegenerative disease models. Our results are consistent with a cytoprotective, rather than a cytotoxic, role for such protein aggregates. National Academy of Sciences 2018-05-29 2018-05-14 /pmc/articles/PMC5984528/ /pubmed/29760078 http://dx.doi.org/10.1073/pnas.1801989115 Text en Copyright © 2018 the Author(s). Published by PNAS. https://creativecommons.org/licenses/by-nc-nd/4.0/ This open access article is distributed under Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle PNAS Plus
Truttmann, Matthias C.
Pincus, David
Ploegh, Hidde L.
Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
title Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
title_full Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
title_fullStr Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
title_full_unstemmed Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
title_short Chaperone AMPylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
title_sort chaperone ampylation modulates aggregation and toxicity of neurodegenerative disease-associated polypeptides
topic PNAS Plus
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5984528/
https://www.ncbi.nlm.nih.gov/pubmed/29760078
http://dx.doi.org/10.1073/pnas.1801989115
work_keys_str_mv AT truttmannmatthiasc chaperoneampylationmodulatesaggregationandtoxicityofneurodegenerativediseaseassociatedpolypeptides
AT pincusdavid chaperoneampylationmodulatesaggregationandtoxicityofneurodegenerativediseaseassociatedpolypeptides
AT ploeghhiddel chaperoneampylationmodulatesaggregationandtoxicityofneurodegenerativediseaseassociatedpolypeptides